Seattle Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Seattle Genetics's estimated annual revenue is currently $1.8B per year.
- Seattle Genetics's estimated revenue per employee is $503,018
- Seattle Genetics's total funding is $1.7B.
- Seattle Genetics's current valuation is $25.1B. (January 2022)
Employee Data
- Seattle Genetics has 3479 Employees.
- Seattle Genetics grew their employee count by 17% last year.
Seattle Genetics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Head Global Regulatory Policy and Intelligence | Reveal Email/Phone |
3 | Director | Reveal Email/Phone |
4 | Associate Director, Program Management | Reveal Email/Phone |
5 | Senior Director Intellectual Property | Reveal Email/Phone |
6 | Chief Technical Officer | Reveal Email/Phone |
7 | Senior Manager | Reveal Email/Phone |
8 | Market Development Manager | Reveal Email/Phone |
9 | Senior Training Manager | Reveal Email/Phone |
10 | Purchasing Manager | Reveal Email/Phone |
Seattle Genetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Seattle Genetics?
Seattle Genetics discovers and develops monoclonal antibody, or mAb-based therapeutics to treat cancer and related diseases. The company has four technologies: engineered mAbs, mAb-drug conjugates,single-chain immunotoxins and ADEPT. We have built a strong corporate culture around the values of integrity, scientific excellence, teamwork, innovation and mutual respect. Seattle Genetics embodies an entrepreneurial spirit that advances breakthrough therapies, which is why we are an acknowledged leader today in antibody-drug conjugate technology.
keywords:N/A
$1.7B
Total Funding
3479
Number of Employees
$1.8B
Revenue (est)
17%
Employee Growth %
$25.1B
Valuation
N/A
Accelerator
Seattle Genetics News
The Seattle Times does not append comment threads to stories from wire services such as the Associated Press, The New York Times, The Washington...
Seagen, previously called Seattle Genetics, focuses on cancer medicines. The company currently has four drugs on the market,...
Formerly known as Seattle Genetics, Seagen has grown to become one of the industry's largest biotechs, with a market value of $26 billion.
Merck & Co. said it is investing $1 billion in Seattle Genetics Inc., as the companies collaborate on developing and selling Seattle Genetics’ breast-cancer treatments. Merck said it is buying five million shares, or 2.9% of shares outstanding, at about $200 a share. Seattle Genetics shares clo ...
Merck & Co. said it is investing $1 billion in Seattle Genetics Inc., as the companies collaborate on developing and selling Seattle Genetics’ breast-cancer treatments. Merck said it is buying five million shares, or 2.9% of shares outstanding, at about $200 a share. Seattle Genetics shares clo ...
Other Companies in Bothell
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1627.6M | 3523 | 5% | N/A |